• Mashup Score: 9

    Pharma giants Merck and Moderna which developed the shot today heralded the results as ‘spectacular’ and a ‘tremendous step forward’. It targets high-risk melanoma.

    Tweet Tweets with this article
    • Wow! 'New paradigm' moment as #mRNA #cancer vaccine developed by Covid shot maker #Moderna slashes risk of tumor relapse or death in melanoma patients by 44%  #CancerResearch https://t.co/n1lVydmNdF @IrmaRaste @eViRaHealth @daniel_kraft #Biotechnology https://t.co/JID1snF1AV

  • Mashup Score: 0

    What’s going on at biotech’s lobbying organization? Where does mRNA go from here? And what happens when startups close down? Find out on the latest episode of “The Readout LOUD” podcast. Listen now:

    Tweet Tweets with this article
    • On this week's episode of “The Readout LOUD” #podcast, @adamfeuerstein discusses his story on Merck paying $250 million to license a #Moderna skin-cancer vaccine candidate. Listen: https://t.co/G1d7K849Ro https://t.co/cbA7qr3PMu